世界の造血系疾患診断・治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hematological Disorders Diagnostic and Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2761 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、造血系疾患診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、物理）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・造血系疾患診断・治療の市場動向 ・企業の競争状況、市場シェア ・造血系疾患診断・治療の種類別市場規模（治療薬、物理） ・造血系疾患診断・治療の用途別市場規模（病院、クリニック） ・造血系疾患診断・治療の北米市場規模2016-2027（アメリカ、カナダ） ・造血系疾患診断・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・造血系疾患診断・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・造血系疾患診断・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・造血系疾患診断・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Amgen、Baxter Healthcare Corporation、Bayer Healthcare Pharmaceuticals、Biogen Idec、Bristol-Myers Squibb、C.R. Bard、Eli Lilly、GE Healthcare、GlaxoSmithKline、Pfizer、Sanofi、Siemens、Teva Pharmaceutical） ・結論

Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in bleeding and clotting processes. People can be affected by many different types of blood disorders.

Market Analysis and Insights: Global Hematological Disorders Diagnostic and Therapeutic Market
The global Hematological Disorders Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hematological Disorders Diagnostic and Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hematological Disorders Diagnostic and Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hematological Disorders Diagnostic and Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hematological Disorders Diagnostic and Therapeutic market.

Global Hematological Disorders Diagnostic and Therapeutic Scope and Market Size
Hematological Disorders Diagnostic and Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hematological Disorders Diagnostic and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug
Physical

Segment by Application
Hospital
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Amgen
Baxter Healthcare Corporation
Bayer Healthcare Pharmaceuticals
Biogen Idec
Bristol-Myers Squibb
C.R. Bard
Eli Lilly
GE Healthcare
Bayer Healthcare Pharmaceuticals
Biogen Idec
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematological Disorders Diagnostic and Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug
1.2.3 Physical
1.3 Market by Application
1.3.1 Global Hematological Disorders Diagnostic and Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hematological Disorders Diagnostic and Therapeutic Market Perspective (2016-2027)
2.2 Hematological Disorders Diagnostic and Therapeutic Growth Trends by Regions
2.2.1 Hematological Disorders Diagnostic and Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hematological Disorders Diagnostic and Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Hematological Disorders Diagnostic and Therapeutic Industry Dynamic
2.3.1 Hematological Disorders Diagnostic and Therapeutic Market Trends
2.3.2 Hematological Disorders Diagnostic and Therapeutic Market Drivers
2.3.3 Hematological Disorders Diagnostic and Therapeutic Market Challenges
2.3.4 Hematological Disorders Diagnostic and Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hematological Disorders Diagnostic and Therapeutic Players by Revenue
3.1.1 Global Top Hematological Disorders Diagnostic and Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Hematological Disorders Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hematological Disorders Diagnostic and Therapeutic Revenue
3.4 Global Hematological Disorders Diagnostic and Therapeutic Market Concentration Ratio
3.4.1 Global Hematological Disorders Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematological Disorders Diagnostic and Therapeutic Revenue in 2020
3.5 Hematological Disorders Diagnostic and Therapeutic Key Players Head office and Area Served
3.6 Key Players Hematological Disorders Diagnostic and Therapeutic Product Solution and Service
3.7 Date of Enter into Hematological Disorders Diagnostic and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hematological Disorders Diagnostic and Therapeutic Breakdown Data by Type
4.1 Global Hematological Disorders Diagnostic and Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Type (2022-2027)

5 Hematological Disorders Diagnostic and Therapeutic Breakdown Data by Application
5.1 Global Hematological Disorders Diagnostic and Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hematological Disorders Diagnostic and Therapeutic Market Size (2016-2027)
6.2 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Type
6.2.1 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2027)
6.3 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Application
6.3.1 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2027)
6.4 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Country
6.4.1 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hematological Disorders Diagnostic and Therapeutic Market Size (2016-2027)
7.2 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Type
7.2.1 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2027)
7.3 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Application
7.3.1 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2027)
7.4 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Country
7.4.1 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Type
8.2.1 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Application
8.3.1 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Region
8.4.1 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size (2016-2027)
9.2 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Type
9.2.1 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Application
9.3.1 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Country
9.4.1 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Type
10.2.1 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Application
10.3.1 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Country
10.4.1 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Hematological Disorders Diagnostic and Therapeutic Introduction
11.1.4 Abbott Laboratories Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Hematological Disorders Diagnostic and Therapeutic Introduction
11.2.4 Amgen Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Baxter Healthcare Corporation
11.3.1 Baxter Healthcare Corporation Company Details
11.3.2 Baxter Healthcare Corporation Business Overview
11.3.3 Baxter Healthcare Corporation Hematological Disorders Diagnostic and Therapeutic Introduction
11.3.4 Baxter Healthcare Corporation Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.3.5 Baxter Healthcare Corporation Recent Development
11.4 Bayer Healthcare Pharmaceuticals
11.4.1 Bayer Healthcare Pharmaceuticals Company Details
11.4.2 Bayer Healthcare Pharmaceuticals Business Overview
11.4.3 Bayer Healthcare Pharmaceuticals Hematological Disorders Diagnostic and Therapeutic Introduction
11.4.4 Bayer Healthcare Pharmaceuticals Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.4.5 Bayer Healthcare Pharmaceuticals Recent Development
11.5 Biogen Idec
11.5.1 Biogen Idec Company Details
11.5.2 Biogen Idec Business Overview
11.5.3 Biogen Idec Hematological Disorders Diagnostic and Therapeutic Introduction
11.5.4 Biogen Idec Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.5.5 Biogen Idec Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Hematological Disorders Diagnostic and Therapeutic Introduction
11.6.4 Bristol-Myers Squibb Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 C.R. Bard
11.7.1 C.R. Bard Company Details
11.7.2 C.R. Bard Business Overview
11.7.3 C.R. Bard Hematological Disorders Diagnostic and Therapeutic Introduction
11.7.4 C.R. Bard Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.7.5 C.R. Bard Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Hematological Disorders Diagnostic and Therapeutic Introduction
11.8.4 Eli Lilly Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 GE Healthcare
11.9.1 GE Healthcare Company Details
11.9.2 GE Healthcare Business Overview
11.9.3 GE Healthcare Hematological Disorders Diagnostic and Therapeutic Introduction
11.9.4 GE Healthcare Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.9.5 GE Healthcare Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Hematological Disorders Diagnostic and Therapeutic Introduction
11.10.4 GlaxoSmithKline Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Hematological Disorders Diagnostic and Therapeutic Introduction
11.11.4 Pfizer Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Hematological Disorders Diagnostic and Therapeutic Introduction
11.12.4 Sanofi Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.12.5 Sanofi Recent Development
11.13 Siemens
11.13.1 Siemens Company Details
11.13.2 Siemens Business Overview
11.13.3 Siemens Hematological Disorders Diagnostic and Therapeutic Introduction
11.13.4 Siemens Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.13.5 Siemens Recent Development
11.14 Teva Pharmaceutical
11.14.1 Teva Pharmaceutical Company Details
11.14.2 Teva Pharmaceutical Business Overview
11.14.3 Teva Pharmaceutical Hematological Disorders Diagnostic and Therapeutic Introduction
11.14.4 Teva Pharmaceutical Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
11.14.5 Teva Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hematological Disorders Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug
Table 3. Key Players of Physical
Table 4. Global Hematological Disorders Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hematological Disorders Diagnostic and Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hematological Disorders Diagnostic and Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Regions (2016-2021)
Table 8. Global Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Regions (2022-2027)
Table 10. Hematological Disorders Diagnostic and Therapeutic Market Trends
Table 11. Hematological Disorders Diagnostic and Therapeutic Market Drivers
Table 12. Hematological Disorders Diagnostic and Therapeutic Market Challenges
Table 13. Hematological Disorders Diagnostic and Therapeutic Market Restraints
Table 14. Global Hematological Disorders Diagnostic and Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Players (2016-2021)
Table 16. Global Top Hematological Disorders Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematological Disorders Diagnostic and Therapeutic as of 2020)
Table 17. Ranking of Global Top Hematological Disorders Diagnostic and Therapeutic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hematological Disorders Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hematological Disorders Diagnostic and Therapeutic Product Solution and Service
Table 21. Date of Enter into Hematological Disorders Diagnostic and Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Type (2016-2021)
Table 25. Global Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hematological Disorders Diagnostic and Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Application (2016-2021)
Table 29. Global Hematological Disorders Diagnostic and Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Hematological Disorders Diagnostic and Therapeutic Product
Table 64. Abbott Laboratories Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Hematological Disorders Diagnostic and Therapeutic Product
Table 69. Amgen Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Baxter Healthcare Corporation Company Details
Table 72. Baxter Healthcare Corporation Business Overview
Table 73. Baxter Healthcare Corporation Hematological Disorders Diagnostic and Therapeutic Product
Table 74. Baxter Healthcare Corporation Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 75. Baxter Healthcare Corporation Recent Development
Table 76. Bayer Healthcare Pharmaceuticals Company Details
Table 77. Bayer Healthcare Pharmaceuticals Business Overview
Table 78. Bayer Healthcare Pharmaceuticals Hematological Disorders Diagnostic and Therapeutic Product
Table 79. Bayer Healthcare Pharmaceuticals Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 80. Bayer Healthcare Pharmaceuticals Recent Development
Table 81. Biogen Idec Company Details
Table 82. Biogen Idec Business Overview
Table 83. Biogen Idec Hematological Disorders Diagnostic and Therapeutic Product
Table 84. Biogen Idec Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 85. Biogen Idec Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Hematological Disorders Diagnostic and Therapeutic Product
Table 89. Bristol-Myers Squibb Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. C.R. Bard Company Details
Table 92. C.R. Bard Business Overview
Table 93. C.R. Bard Hematological Disorders Diagnostic and Therapeutic Product
Table 94. C.R. Bard Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 95. C.R. Bard Recent Development
Table 96. Eli Lilly Company Details
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 99. Eli Lilly Recent Development
Table 100. GE Healthcare Company Details
Table 101. GE Healthcare Business Overview
Table 102. GE Healthcare Hematological Disorders Diagnostic and Therapeutic Product
Table 103. GE Healthcare Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 104. GE Healthcare Recent Development
Table 105. GlaxoSmithKline Company Details
Table 106. GlaxoSmithKline Business Overview
Table 107. GlaxoSmithKline Hematological Disorders Diagnostic and Therapeutic Product
Table 108. GlaxoSmithKline Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 109. GlaxoSmithKline Recent Development
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer Hematological Disorders Diagnostic and Therapeutic Product
Table 113. Pfizer Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 114. Pfizer Recent Development
Table 115. Sanofi Company Details
Table 116. Sanofi Business Overview
Table 117. Sanofi Hematological Disorders Diagnostic and Therapeutic Product
Table 118. Sanofi Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 119. Sanofi Recent Development
Table 120. Siemens Company Details
Table 121. Siemens Business Overview
Table 122. Siemens Hematological Disorders Diagnostic and Therapeutic Product
Table 123. Siemens Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 124. Siemens Recent Development
Table 125. Teva Pharmaceutical Company Details
Table 126. Teva Pharmaceutical Business Overview
Table 127. Teva Pharmaceutical Hematological Disorders Diagnostic and Therapeutic Product
Table 128. Teva Pharmaceutical Revenue in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021) & (US$ Million)
Table 129. Teva Pharmaceutical Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Drug Features
Figure 3. Physical Features
Figure 4. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Hematological Disorders Diagnostic and Therapeutic Report Years Considered
Figure 8. Global Hematological Disorders Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Hematological Disorders Diagnostic and Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Regions: 2020 VS 2027
Figure 11. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Regions (2022-2027)
Figure 12. Global Hematological Disorders Diagnostic and Therapeutic Market Share by Players in 2020
Figure 13. Global Top Hematological Disorders Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hematological Disorders Diagnostic and Therapeutic as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Hematological Disorders Diagnostic and Therapeutic Revenue in 2020
Figure 15. Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Type (2016-2021)
Figure 16. Global Hematological Disorders Diagnostic and Therapeutic Revenue Market Share by Type (2022-2027)
Figure 17. North America Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 19. North America Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 20. North America Hematological Disorders Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 21. United States Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 25. Europe Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 26. Europe Hematological Disorders Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 27. Germany Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Hematological Disorders Diagnostic and Therapeutic Market Share by Region (2016-2027)
Figure 37. China Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 45. Latin America Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 46. Latin America Hematological Disorders Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 47. Mexico Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Hematological Disorders Diagnostic and Therapeutic Market Share by Country (2016-2027)
Figure 53. Turkey Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Hematological Disorders Diagnostic and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Abbott Laboratories Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 57. Amgen Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 58. Baxter Healthcare Corporation Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 59. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 60. Biogen Idec Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 62. C.R. Bard Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 64. GE Healthcare Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 68. Siemens Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 69. Teva Pharmaceutical Revenue Growth Rate in Hematological Disorders Diagnostic and Therapeutic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---